PNC Financial Services Group Inc. cut its position in shares of Hill-Rom Holdings Inc. (NYSE:HRC) by 4.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 358,039 shares of the medical technology company’s stock after selling 16,340 shares during the period. PNC Financial Services Group Inc. owned 0.55% of Hill-Rom Holdings worth $22,192,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Geode Capital Management LLC increased its position in shares of Hill-Rom Holdings by 3.4% in the first quarter. Geode Capital Management LLC now owns 357,514 shares of the medical technology company’s stock worth $17,982,000 after buying an additional 11,790 shares in the last quarter. Metropolitan Life Insurance Co. NY increased its position in shares of Hill-Rom Holdings by 3.0% in the first quarter. Metropolitan Life Insurance Co. NY now owns 53,881 shares of the medical technology company’s stock worth $2,710,000 after buying an additional 1,565 shares in the last quarter. Barclays PLC increased its position in shares of Hill-Rom Holdings by 11.8% in the first quarter. Barclays PLC now owns 19,532 shares of the medical technology company’s stock worth $976,000 after buying an additional 2,055 shares in the last quarter. BNP Paribas Arbitrage SA increased its position in shares of Hill-Rom Holdings by 3,757.5% in the second quarter. BNP Paribas Arbitrage SA now owns 23,608 shares of the medical technology company’s stock worth $1,191,000 after buying an additional 22,996 shares in the last quarter. Finally, Fisher Asset Management LLC increased its position in shares of Hill-Rom Holdings by 0.4% in the second quarter. Fisher Asset Management LLC now owns 1,576,535 shares of the medical technology company’s stock worth $80,466,000 after buying an additional 5,975 shares in the last quarter. 82.55% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Hill-Rom Holdings Inc. (NYSE:HRC) traded down 0.16% during midday trading on Tuesday, reaching $54.56. 219,446 shares of the company traded hands. Hill-Rom Holdings Inc. has a 12 month low of $42.99 and a 12 month high of $63.12. The stock has a market capitalization of $3.59 billion, a price-to-earnings ratio of 29.33 and a beta of 1.20. The firm has a 50 day moving average of $56.90 and a 200-day moving average of $54.98.

Hill-Rom Holdings (NYSE:HRC) last released its quarterly earnings results on Thursday, November 3rd. The medical technology company reported $1.18 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.13 by $0.05. Hill-Rom Holdings had a net margin of 4.67% and a return on equity of 18.93%. The business had revenue of $706 million for the quarter, compared to analyst estimates of $701.39 million. During the same quarter in the previous year, the business earned $0.89 earnings per share. The firm’s revenue was up 23.0% compared to the same quarter last year. Analysts forecast that Hill-Rom Holdings Inc. will post $3.78 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 30th. Investors of record on Friday, December 16th will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.24%. The ex-dividend date of this dividend is Wednesday, December 14th. Hill-Rom Holdings’s payout ratio is presently 36.76%.

ILLEGAL ACTIVITY WARNING: “PNC Financial Services Group Inc. Cuts Position in Hill-Rom Holdings Inc. (HRC)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2016/11/29/pnc-financial-services-group-inc-cuts-position-in-hill-rom-holdings-inc-hrc.html.

Separately, Zacks Investment Research raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $64.00 target price on the stock in a research note on Tuesday, August 9th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Hill-Rom Holdings has an average rating of “Buy” and an average price target of $62.20.

In related news, COO Carlyn D. Solomon sold 40,515 shares of the business’s stock in a transaction that occurred on Thursday, November 17th. The shares were sold at an average price of $54.78, for a total transaction of $2,219,411.70. Following the transaction, the chief operating officer now directly owns 22,163 shares of the company’s stock, valued at $1,214,089.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.10% of the company’s stock.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.

5 Day Chart for NYSE:HRC

Receive News & Stock Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related stocks with our FREE daily email newsletter.